© John Wiley & Sons, Ltd.
Editor-in-Chief: Professor Diana W. Bianchi, Boston, USA
Impact Factor: 2.514
ISI Journal Citation Reports © Ranking: 2013: 18/78 (Obstetrics & Gynecology); 88/164 (Genetics & Heredity)
Online ISSN: 1097-0223
Welcome to the Prenatal Diagnosis Virtual Issues page
List of issues
Issue 5, April 2013 Fetal therapy for infections and red cell alloimmunisation
Issue 4, March 2013 Prenatal Diagnosis using Microarrays
Issue 3, October 2012: Placental serum and Doppler markers for the prediction of adverse obstetric outcomes
Issue 2, May 2012: USS diagnosis of genetic syndromes
Issue 1, April 2011: Echocardiography
Issue 5, April 2013 Fetal therapy for infections and red cell alloimmunisation
Fetal therapy for infections and red cell alloimmunisation
Comparison of prevalence of toxoplasma and cytomegalovirus infection in cases with fetal ultrasound markers in the second trimester of pregnancy
Parvovirus B19 infection in pregnancy: new insights and management
|3|| Pitfalls in the diagnosis of congenital rubella syndrome in the first trimester of pregnancy|
(pages 496–497) A. G. Cordier, C. Vauloup-Fellous, L. Grangeot-Keros, C. Pinet, A. Benachi, J. M. Ayoubi and O. Picone 2012, 32
|4|| Fetal varicella – diagnosis, management, and outcome|
(pages 511–518) Laurent Mandelbrot 2012,32:
|5|| Maternal IgM antibody status in confirmed fetal cytomegalovirus infection detected by sonographic signs|
(pages 817–821) Anna Goncé, M. Angeles Marcos, Antoni Borrell, Marta López, Alfons Nadal, Francesc Figueras and Eduard Gratacós 2012, 32
|6|| Parvovirus B19 in pregnancy: possible consequences of vertical transmission|
(pages 897–902) C. Puccetti, M. Contoli, F. Bonvicini, F. Cervi, G. Simonazzi, G. Gallinella, P. Murano, A. Farina, B. Guerra, M. Zerbini and N. Rizzo 2012,32
|7|| Does normal fetal brain ultrasound predict normal neurodevelopmental outcome in congenital cytomegalovirus infection?|
PRENATAL DIAGNOSIS Volume 31, Issue 4, April 2011, Pages: 360–366, Natalie Farkas, Chen Hoffmann, Liat Ben-Sira, Dorit Lev, Avraham Schweiger, Dvora Kidron, Tally Lerman-Sagie and Gustavo Malinger
|8|| Periconceptional cytomegalovirus infection: pregnancy outcome and rate of vertical transmission|
PRENATAL DIAGNOSIS Volume 30, Issue 12-13, December 2010, Pages: 1213–1216, Eran Hadar, Yariv Yogev, Nir Melamed, Rony Chen, Jacob Amir and Josef Pardo
|9|| Management of red cell alloimmunisation in pregnancy: the non-invasive monitoring of the disease|
PRENATAL DIAGNOSIS Volume 30, Issue 7, July 2010, Pages: 668–673, Sebastian Illanes and Peter Soothill
|10|| Prediction of the rate of decline in fetal hemoglobin levels between first and second transfusions in red cell alloimmune disease|
PRENATAL DIAGNOSIS Volume 32, Issue 12, December 2012, Pages: 1123–1126, Estela Naomi Nishie, Adolfo Wenjaw Liao, Maria de Loudes Brizot, Renata A. Assunção and Marcelo Zugaib
|11|| A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome|
1 May 2013, Pages: 1-8, O. Picone, C. Vauloup-Fellous, A. G. Cordier, S. Guitton, M. V. Senat, F. Fuchs, J. M. Ayoubi, L. Grangeot Keros A. Benachi
Prenatal Diagnosis Virtual Issue Number 4, March 2013
Prenatal Diagnosis using Microarrays
Genomic microarrays: a technology overview
Experience with microarray-based comparative genomic hybridization for prenatal diagnosis in over 5000 pregnancies
|3|| Detection rates of clinically significant genomic alterations by microarray analysis for specific anomalies detected by ultrasound|
PRENATAL DIAGNOSIS Volume 32, Issue 10, October 2012, Pages: 986–995, Lisa G. Shaffer, Jill A. Rosenfeld, Mindy P. Dabell, Justine Coppinger, Anne M. Bandholz, Jay W. Ellison, J. Britt Ravnan, Beth S. Torchia, Blake C. Ballif and Allan J. Fisher
|4|| Prenatal chromosomal microarray analysis in a diagnostic laboratory; experience with >1000 cases and review of the literature|
PRENATAL DIAGNOSIS Volume 32, Issue 4, April 2012, Pages: 351–361, Amy Breman, Amber N. Pursley, Patricia Hixson, Weimin Bi, Patricia Ward, Carlos A. Bacino, Chad Shaw, James R. Lupski, Arthur Beaudet, Ankita Patel, Sau W. Cheung and Ignatia Van den Veyver
|5|| Introducing array comparative genomic hybridization into routine prenatal diagnosis practice: a prospective study on over 1000 consecutive clinical cases|
PRENATAL DIAGNOSIS Volume 31, Issue 13, December 2011, Pages: 1270–1282, Francesco Fiorentino, Fiorina Caiazzo, Stefania Napolitano, Letizia Spizzichino, Sara Bono, Mariateresa Sessa, Andrea Nuccitelli, Anil Biricik, Anthony Gordon, Giuseppe Rizzo and Marina Baldi
|6|| Non-targeted whole genome 250K SNP array analysis as replacement for karyotyping in fetuses with structural ultrasound anomalies: evaluation of a one-year experience|
PRENATAL DIAGNOSIS Volume 32, Issue 4, April 2012, Pages: 362–370, Brigitte HW Faas, Ilse Feenstra, Alex J. Eggink, Angelique JA Kooper, Rolph Pfundt, John MG van Vugt and Nicole de Leeuw
|7|| Prenatal genetic diagnosis using microarray analysis in fetuses with congenital heart defects|
PRENATAL DIAGNOSIS Volume 32, Issue 4, April 2012, Pages: 376–382, Maximilian Schmid, Susanne Stary, Wibke Blaicher, Michaela Gollinger, Peter Husslein and Berthold Streubel
|8|| Array CGH analysis in high-risk pregnancies: comparing DNA from cultured cells and cell-free fetal DNA|
PRENATAL DIAGNOSIS Volume 32, Issue 4, April 2012, Pages: 383–388, Nicolas Gruchy, Matthieu Decamp, Nicolas Richard, Corinne Jeanne-Pasquier, Guillaume Benoist, Hervé Mittre and Nathalie Leporrier
|9|| Detection of ≥1 Mb microdeletions and microduplications in a single cell using custom oligonucleotide arrays|
PRENATAL DIAGNOSIS Volume 32, Issue 1, January 2012, Pages: 10–20, Weimin Bi, Amy Breman, Chad A. Shaw, Pawel Stankiewicz, Tomasz Gambin, Xinyan Lu, Sau Wai Cheung, Laird G. Jackson, James R. Lupski, Ignatia B. Van den Veyver and Arthur L. Beaudet
|10|| Genetic counselling and ethical issues with chromosome microarray analysis in prenatal testing|
PRENATAL DIAGNOSIS Volume 32, Issue 4, April 2012, Pages: 389–395, George McGillivray, Jill A Rosenfeld, R. J. McKinlay Gardner and Lynn H. Gillam
|11|| Integration of microarray technology into prenatal diagnosis: counselling issues generated during the NICHD clinical trial|
PRENATAL DIAGNOSIS Volume 32, Issue 4, April 2012, Pages: 396–400, Ronald J. Wapner, Deborah A. Driscoll and Joe Leigh Simpson
|12|| Prenatal chromosomal microarray analysis: a survey of prenatal genetic counselors' experiences and attitudes|
PRENATAL DIAGNOSIS Marina Mikhaelian, Patricia McCarthy Veach, Ian MacFarlane, Bonnie S. LeRoy and Matthew Bower
Prenatal Diagnosis Virtual Issue Number 3, October 2012
Placental serum and Doppler markers for the prediction of adverse obstetric outcomes
|1||A model for a new pyramid of prenatal care based on the 11 to 13 weeks’ assessment|
Prenatal Diagnosis 2011; 31: 3–6.
|2||Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks|
Ranjit Akolekar, Argyro Syngelaki, Rita Sarquis, Mona Zvanca and Kypros H. Nicolaides
Prenatal Diagnosis 2011; 31: 66–74.
|3||Placental volume and three-dimensional power Doppler analysis in prediction of pre-eclampsia and small for gestational age between Week 11 and 13 weeks and 6 days of gestation|
Marwan Odeh, Ella Ophir, Olga Maximovsky, Vitali Grinin and Jacob Bornstein
Prenatal Diagnosis 2011; 31: 367–371.
|4||Reference range of birth weight with gestation and first-trimester prediction of small-for-gestation neonates|
Leona Poon, George Karagiannis, Ismini Staboulidou, Akram Shafiei and Kypros H. Nicolaides
Prenatal Diagnosis 2011; 31: 58–65.
|5||First trimester screening for intra-uterine growth restriction and early-onset pre-eclampsia|
G. Vandenberghe, I. Mensink, J. W. R. Twisk, M. A. Blankenstein, A. C. Heijboer and J. M. G. van Vugt
Prenatal Diagnosis 2011; 31: 955–961.
|6||Prospective evaluation of ultrasound and biochemical-based multivariable models for the prediction of late pre-eclampsia|
Antonio Farina, Giuseppina Rapacchia, Anna Freni Sterrantino, Giulia Pula, Danila Morano and Nicola Rizzo
Prenatal Diagnosis 2011; 31: 1147–1152.
|7||Doppler and Biochemical Screening for Preeclampsia|
Aly Youssef, Francesca Righetti, Danila Morano, Nicola Rizzo and Antonio Farina
Prenatal Diagnosis 2011; 31: 1141–1146.
|8||First-trimester prediction of preterm birth using ADAM12, PAPP-A, uterine artery Doppler, and maternal characteristics|
Katherine R. Goetzinger, Alison G. Cahill, Janet Kemna, Linda Odibo, George A. Macones and Anthony O. Odibo
Prenatal Diagnosis2012; 32: 1002–1007.
|9||Screening for pre-eclampsia by using changes in uterine artery Doppler indices with advancing gestation|
Raffaele Napolitano, Karen Melchiorre, Tiziana Arcangeli, Tiran Dias, Amar Bhide and Basky Thilaganathan
Prenatal Diagnosis 2012; 32: 180–184.
|10||Predictive rules for adverse pregnancy outcome|
R. van Ravenswaaij, M. Tesselaar-van der Goot, S. de Wolf, M. van Leeuwen-Spruijt, G. H. A. Visser and P. C. J. I. Schielen
Prenatal Diagnosis 2011; 31: 50–57.
|11||First-trimester prediction of preeclampsia using metabolomic biomarkers: a discovery phase study|
Anthony O. Odibo, Katherine R. Goetzinger, Linda Odibo, Alison G. Cahill, George A. Macones, D. Michael Nelson and Dennis J. Dietzen
Prenatal Diagnosis 2011; 31: 990–994.
|12||Integrative data mining to identify novel candidate serum biomarkers for pre-eclampsia screening|
Jeroen L. A. Pennings, Sylwia Kuc, Wendy Rodenburg, Maria P. H. Koster, Peter C. J. I. Schielen and Annemieke de Vries
Prenatal Diagnosis 2011; 31: 1153–1159.
|13||Evaluation of placental syndecan-1 expression in early pregnancy as a predictive fetal factor for pregnancy outcome|
Anna Schmedt, Martin Götte, Jörg Heinig, Ludwig Kiesel, Walter Klockenbusch and Johannes Steinhard
Prenatal Diagnosis 2012; 32: 131–137.
Prenatal Diagnosis Virtual Issue Number 2, May 2012
USS diagnosis of genetic syndromes
|1||A clinical algorithm of prenatal diagnosis of Radial Ray Defects with two and three dimensional ultrasound|
Máiréad M. Kennelly and Paul Moran
Prenatal Diagnosis 2007; 27: 730–737.
|2||Diagnosis of Apert syndrome in the second-trimester using 2D and 3D ultrasound|
A. David, C. Turnbull, R. Scott, J. Freeman, C. M. Bilardo, M. van Maarle, L. S. Chitty
Prenatal Diagnosis 2007; 27: 629–632.
|3||Cornelia de Lange syndrome (CdLS): prenatal and autopsy findings|
Karen Chong, Sarah Keating, Stephanie Hurst, Anne Summers, Howard Berger, Gareth Seaward, Nicole Martin, Tami Friedberg, David Chitayat
Prenatal Diagnosis 2009; 29: 489–494.
|4||Brachmann–de Lange syndrome: definition of prenatal sonographic features to facilitate definitive prenatal diagnosis|
E. Pajkrt, D. R. Griffin, L. S. Chitty
Prenatal Diagnosis 2010; 30: 865–872.
|5||Prader-Willi syndrome: is there a recognizable fetal phenotype?|
Nicole Bigi, Jean-Michel Faure, Christine Coubes, Jacques Puechberty, Geneviève Lefort, Pierre Sarda, Patricia Blanchet
Prenatal Diagnosis 2008; 28: 796–799.
|6||Genetic considerations in the prenatal diagnosis of overgrowth syndromes|
Neeta Vora and Diana W. Bianchi
Prenatal Diagnosis 2009; 29: 923–929.
|7||Syndromic associations with congenital anomalies of the fetal thorax and abdomen|
Jane Hurst, Helen V. Firth, Lyn S. Chitty
Prenatal Diagnosis 2008; 28: 676-684.
|8||Fetal genital anomalies: an aid to diagnosis|
Eva Pajkrt, Olav B. Petersen, Lyn S. Chitty.
Prenatal Diagnosis 2008; 28: 389–398.
|9||Prenatal diagnosis of non-immune hydrops fetalis: what do we tell the parents?|
Susana Santo, Sahar Mansour, Basky Thilaganathan, Tessa Homfray, Aris Papageorghiou, Sandra Calvert, Amar Bhide
Prenatal Diagnosis 2011; 31: 186–195.
|10||Prenatal features of Costello syndrome: ultrasonographic findings and atrial tachycardia|
Angela E. Lin, Barbara O'Brien, Laurie A. Demmer, Kristina K. Almeda, Cynthia L. Blanco, Patrick F. Glasow, Charles I. Berul, Robert Hamilton, A. Micheil Innes, Julie L. Lauzon, Katia Sol-Church, Karen W. Gripp
Prenatal Diagnosis 2009; 29: 682-690.
|11||Galactosialidosis presenting as nonimmune fetal hydrops: a case report|
Susana Carvalho, Márcia Martins, Ana Fortuna, Umbelina Ramos, Carlos Ramos, Maria Céu Rodrigues
Prenatal Diagnosis 2009; 29: 895-896.
|12||Prenatal diagnosis and natural history of fetuses presenting with pleural effusion|
Rodrigo Ruano, Alan Saito Ramalho, Ana Karina Silva Cardoso, Kenneth Moise Jr and Marcelo Zugaib
Prenatal Diagnosis 2011; 31: 496-499.
|13||Increased nuchal translucency in euploid fetuses—what should we be telling the parents?|
C.M. Bilardo, E. Timmerman, E. Pajkrt and M. van Maarle
Prenatal Diagnosis 2010; 30: 93-102.
|14||Genetic assessment following increased nuchal translucency and normal karyotype|
Eugene Pergament, Christina Alamillo, Katrin Sak and Morris Fiddler
Prenatal Diagnosis 2011; 31: 307-310.
|15||Targeted ultrasound examination and DNA testing for Noonan syndrome, in fetuses with increased nuchal translucency and normal karyotype|
M. Bakker, E. Pajkrt, I. B. Mathijssen and C. M. Bilardo
Prenatal Diagnosis 2011; 31: 833-840.
|16||Prenatal features of Noonan syndrome: prevalence and prognostic value|
G. Baldassarre, A. Mussa, A. Dotta, E. Banaudi, S. Forzano, A. Marinosci, C. Rossi, M. Tartaglia, M. Silengo and G. B. Ferrero
Prenatal Diagnosis 2011; 31: 949-954.
|17|| Male genital abnormalities in intrauterine growth restriction|
(pages 427–431) Stefan F. Nemec, Ursula Nemec, Peter C. Brugger, Dieter Bettelheim, Michael Weber, John M. Graham Jr., David L. Rimoin and Daniela Prayer Article first published online: 11 APR 2012 | DOI: 10.1002/pd.3831
|18||Male genital abnormalities in intrauterine growth restriction|
S. F. Nemec, U. Nemec, P. C. Brugger, D. Bettelheim, M. Weber, J. M. Graham, D. L. Rimoin and D. Prayer
Prenatal Diagnosis 2012; 32: 427–431.
|19||Fetal forearm anomalies: prenatal diagnosis, associations and management strategy|
E. Pajkrt, S. Cicero, D. Griffin, M. Maarle and L. S. Chitty
Prenatal Diagnosis 2012; 32: 1084–1093.
|20||Fast protocol for the diagnosis of lysosomal diseases in nonimmune hydrops fetalis|
L. Gort, M. R. Granell, G. Fernández, P. Carreto, A. Sanchez and M. José Coll
Prenatal Diagnosis 2012; 32: 1139–1142.
|21|| Fetal forearm anomalies: prenatal diagnosis, associations and management strategy|
(pages 1084–1093) Eva Pajkrt, Simona Cicero, David R. Griffin, M. C. van Maarle and Lyn S. Chitty Article first published online: 18 AUG 2012 | DOI: 10.1002/pd.3962
|22|| Fast protocol for the diagnosis of lysosomal diseases in nonimmune hydrops fetalis|
(pages 1139–1142) Laura Gort, M. Reyes Granell, Gema Fernández, Práxedes Carreto, Aurora Sanchez and M. José Coll Article first published online: 18 SEP 2012 | DOI: 10.1002/pd.3972
Prenatal Diagnosis Virtual Issue Number 1, April 2011
|1||The nuchal translucency and the fetal heart: a literature review|
S. A. Clur, J. Ottenkamp, C. M. Bilardo
Prenatal Diagnosis 2009; 29: 739-748.
|2||Fetal cardiac scanning today|
Prenatal Diagnosis 2010; 30: 639-643.
|3||2010 Report from the ISPD Special Interest Group fetal therapy: fetal cardiac interventions|
D. Oepkes, A. J. Moon-Grady, L. Wilkins-Haug, W. Tworetzky, W. Arzt, R. Devlieger
Prenatal Diagnosis 2011; 31: 249-251.
|4||Methods for prenatal assessment of fetal cardiac function|
Tim Van Mieghem, Philip DeKoninck, Patricia Steenhaut, Jan Deprest
Prenatal Diagnosis 2009; 29: 1193-1203.
|5||Three and four dimensional ultrasound: a novel method for evaluating fetal cardiac anomalies|
L. Gindes, J. Hegesh, B. Weisz, Y. Gilboa, R. Achiron
Prenatal Diagnosis 2009; 29: 645-653.
|6||Evaluation of normal fetal atrio-ventricular septum dimensions during pregnancy|
Jimmy E. Jadaon, Sami Haddad, Maggi Mukary, Izhar Ben-Shlomo, Moshe Ben-Ami
Prenatal Diagnosis 2011; 31: 167-170.
|7||Fetal cardiac tumors: a single-center experience of 40 cases|
Yoav Yinon, David Chitayat, Susan Blaser, Mike Seed, Hagai Amsalem, Shi-Joon Yoo, Edgar T. Jaeggi
Prenatal Diagnosis 2010; 30: 941-949.
|8||Structural heart defects associated with an increased nuchal translucency: 9 years experience in a referral centre|
S. A. Clur, I. B. Mathijssen, E. Pajkrt, A. Cook, R. N. Laurini, J. Ottenkamp, C. M. Bilardo
Prenatal Diagnosis 2008; 28: 347-354.
|9||Influence of maternal BMI on genetic sonography in the FaSTER trial|
Kjersti M. Aagaard-Tillery, T. Flint Porter, Fergal D. Malone, David A. Nyberg, Jamie Collins, Christine H. Comstock, Gary Hankins, Keith Eddleman, Lorraine Dugoff, Honor M. Wolfe, Mary E. D'Alton
Prenatal Diagnosis 2010; 30: 14-22.
|10||Prospective experience with integrated prenatal screening and first trimester combined screening for trisomy 21 in a large Canadian urban center|
Nanette Okun, Anne M. Summers, Barry Hoffman, Tianhua Huang, Elizabeth Winsor, David Chitayat, A. Staines, Jo-Ann Johnson
Prenatal Diagnosis 2008; 28: 987-992.
|11||Results of in utero atrial septoplasty in fetuses with hypoplastic left heart syndrome|
Audrey C. Marshall, Jami Levine, Donna Morash, Virginia Silva, James E. Lock, Carol B. Benson, Louise E. Wilkins-Haug, Doff B. McElhinney, Wayne Tworetzky
Prenatal Diagnosis 2008; 28: 1023-1028.
|12||Outcome following prenatal diagnosis of complete atrioventricular septal defect|
S. V. Rasiah, A. K. Ewer, P. Miller, J. G. Wright, A. Tonks, M. D. Kilby
Prenatal Diagnosis 2008; 28: 95-101.
|13||Influence of ultrasonographers training on prenatal diagnosis of congenital heart diseases: a 12-year population-based study|
Ph. Pézard, L. Bonnemains, F. Boussion, L. Sentilhes, P. Allory, C. Lépinard, A. Guichet, S. Triau, F. Biquard, M. Leblanc, D. Bonneau, Ph. Descamps
Prenatal Diagnosis 2008; 28: 1016-1022.
|14||Absent ductus venosus – outcomes and implications from a tertiary centre|
J. Thomas, S. Petersen, R. Cincotta, A. Tannock and G. Gardener
Prenatal Diagnosis 2012; 32: 686–691.
|15||Screening performance for trisomy 21 comparing first trimester combined screening and a first trimester contingent screening protocol including ductus venosus and tricuspid flow|
C. K. Ekelund, O. B. Petersen, K. Sundberg, F. Pedersen, I. Vogel, A. Tabor
Prenatal Diagnosis 2012; 40: 195.
|16||Fetal cardiac anomalies and genetic syndromes|
E. Pajkrt, B. Weisz, H. Firth and L. Chitty
Prenatal Diagnosis 2004; 1104–1115.
Return to top